Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients

Clinical Transplantation

Volumn 25, Issue 5, 2011, Pages 755-765

  Ecochard, Marie ^a   Boillot, Olivier ^a   Guillaud, Olivier ^a   Roman, Sabine ^b   Adham, Mustapha ^a   Mion, François ^b   Dumortier, Jérôme ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Listing; Liver function; Liver transplantation; Model for End Stage Liver Disease; Prognosis

Indexed keywords

AMINOPHENAZONE; GALACTOSE; INDOCYANINE GREEN;

ADULT; AMINOPHENAZONE BREATH TEST; ARTICLE; BREATH ANALYSIS; CHILD TURCOTTE PUGH SCORE; CLINICAL ASSESSMENT TOOL; FEMALE; FOLLOW UP; GALACTOSE ELIMINATION CAPACITY; GRAFT SURVIVAL; HOSPITAL ADMISSION; HUMAN; INDOCYANINE GREEN RETENTION RATE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURGICAL MORTALITY; SURVIVAL RATE;

ADULT; AGED; AMINOPYRINE; BREATH TESTS; COLORING AGENTS; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GALACTOSE; HUMANS; INDOCYANINE GREEN; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; RESOURCE ALLOCATION; SURVIVAL RATE; WAITING LISTS; YOUNG ADULT;

EID: 80054108680     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01366.x     Document Type: Article

References (33)

1. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964: 1: 1.
2. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973: 60: 646.
3. Christensen E, Schlichting P, Andersen PK et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986: 21: 163.
4. Gines P, Quintero E, Arroyo V et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987: 7: 122.
5. Poynard T, Naveau S, Doffoel M et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group. J Hepatol 1999: 30: 1130.
6. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001: 33: 464.
7. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000: 31: 864.
8. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007: 45: 797.
9. Merkel C, Bolognesi M, Finucci GF et al. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis. J Hepatol 1989: 9: 16.
10. Merkel C, Bolognesi M, Bellon S et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992: 33: 836.
11. Merkel C, Marchesini G, Fabbri A et al. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology 1996: 24: 820.
12. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960: 39: 592.
13. Lau H, Man K, Fan ST, Yu WC et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997: 84: 1255.
14. Hepner GW, Vesell ES. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine. Ann Intern Med 1975: 83: 632.
15. Urbain D, Muls V, Thys O, Ham HR. Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B. J Hepatol 1995: 22: 179.
16. Urbain D, Jeghers O, Thys O, Vanderauwera J, Ham HR. Aminopyrine breath test in alcoholic cirrhosis. Nucl Med Commun 1990: 11: 289.
17. Mion F, Rousseau M, Scoazec JY, Berger F, Minaire Y. [13C]-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C. Eur J Clin Invest 1999: 29: 624.
18. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982: 143: 29.
19. Villeneuve JP, Infante-Rivard C, Ampelas M, Pomier-Layrargues G, Huet PM, Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 1986: 6: 928.
20. Mion F, Queneau PE, Rousseau M, Brazier JL, Paliard P, Minaire Y. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans. Hepatogastroenterology 1995: 42: 931.
21. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005: 42(Suppl 1): S100.
22. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? J Hepatol 2004: 41: 344.
23. Cholongitas E, Marelli L, Shusang V et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006: 12: 1049.
24. Hori T, Iida T, Yagi S et al. (ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl 2006: 12: 605.
25. Oellerich M, Burdelski M, Lautz HU et al. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 1991: 14: 1029.
26. Oellerich M, Burdelski M, Lautz HU et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991: 51: 801.
27. Merkel C, Gatta A, Zoli M et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 1991: 36: 1197.
28. Degre D, Bourgeois N, Boon N et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int 2004: 17: 31.
29. Salerno F, Borroni G, Moser P et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. J Hepatol 1996: 25: 474.
30. Desai NM, Mange KC, Crawford MD et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004: 77: 99.
31. Onaca NN, Levy MF, Sanchez EQ et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003: 9: 117.
32. Jacob M, Copley LP, Lewsey JD et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004: 10: 903.
33. Merion RM, Schaubel DE, Dykstra DM et al. The survival benefit of liver transplantation. Am J Transplant 2005: 5: 307.